Group One Trading’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.64M | Sell |
301,700
-69,200
| -19% | -$388K | ﹤0.01% | 2246 |
|
|
2025
Q4 | $2.6M | Buy |
370,900
+215,800
| +139% | +$1.69M | ﹤0.01% | 2042 |
|
|
2025
Q3 | $1.2M | Buy |
155,100
+97,100
| +167% | +$758K | ﹤0.01% | 2839 |
|
|
2025
Q2 | $505K | Sell |
58,000
-2,900
| -5% | -$21K | ﹤0.01% | 3416 |
|
|
2025
Q1 | $485K | Sell |
60,900
-44,600
| -42% | -$451K | ﹤0.01% | 3114 |
|
|
2024
Q4 | $959K | Sell |
105,500
-8,100
| -7% | -$78.2K | ﹤0.01% | 2615 |
|
|
2024
Q3 | $1.04M | Buy |
113,600
+17,800
| +19% | +$147K | ﹤0.01% | 2255 |
|
|
2024
Q2 | $937K | Buy |
95,800
+47,000
| +96% | +$573K | ﹤0.01% | 2038 |
|
|
2024
Q1 | $737K | Buy |
48,800
+6,300
| +15% | +$114K | ﹤0.01% | 2366 |
|
|
2023
Q4 | $916K | Buy |
42,500
+19,900
| +88% | +$367K | ﹤0.01% | 2533 |
|
|
2023
Q3 | $420K | Sell |
22,600
-87,700
| -80% | -$2.05M | ﹤0.01% | 3080 |
|
|
2023
Q2 | $2.79M | Sell |
110,300
-71,500
| -39% | -$1.8M | 0.01% | 1408 |
|
|
2023
Q1 | $4.71M | Buy |
181,800
+75,400
| +71% | +$2.02M | 0.02% | 872 |
|
|
2022
Q4 | $2.52M | Sell |
106,400
-493,600
| -82% | -$13.3M | 0.01% | 1638 |
|
|
2022
Q3 | $15.2M | Sell |
600,000
-208,200
| -26% | -$7.3M | 0.03% | 510 |
|
|
2022
Q2 | $26.8M | Sell |
808,200
-627,300
| -44% | -$26.6M | 0.04% | 361 |
|
|
2022
Q1 | $104M | Sell |
1,435,500
-366,300
| -20% | -$26.4M | 0.1% | 120 |
|
|
2021
Q4 | $165M | Buy |
1,801,800
+167,200
| +10% | +$20M | 0.13% | 79 |
|
|
2021
Q3 | $207M | Buy |
1,634,600
+91,300
| +6% | +$13.3M | 0.22% | 48 |
|
|
2021
Q2 | $257M | Buy |
1,543,300
+1,090,100
| +241% | +$177M | 0.31% | 34 |
|
|
2021
Q1 | $82.4M | Buy |
453,200
+211,300
| +87% | +$49M | 0.12% | 117 |
|
|
2020
Q4 | $48.4M | Buy |
241,900
+112,500
| +87% | +$22.9M | 0.08% | 193 |
|
|
2020
Q3 | $28.4M | Sell |
129,400
-53,000
| -29% | -$11.2M | 0.09% | 183 |
|
|
2020
Q2 | $34.8M | Buy |
182,400
+94,600
| +108% | +$16.6M | 0.16% | 105 |
|
|
2020
Q1 | $13.6M | Buy |
87,800
+26,200
| +43% | +$3.05M | 0.11% | 168 |
|
|
2019
Q4 | $5.16M | Sell |
61,600
-6,500
| -10% | -$495K | 0.04% | 673 |
|
|
2019
Q3 | $4.61M | Buy |
68,100
+13,600
| +25% | +$895K | 0.04% | 622 |
|
|
2019
Q2 | $3.62M | Buy |
54,500
+200
| +0.4% | +$11.7K | 0.03% | 706 |
|
|
2019
Q1 | $3.02M | Sell |
54,300
-30,600
| -36% | -$1.87M | 0.03% | 678 |
|
|
2018
Q4 | $4.21M | Buy |
84,900
+43,400
| +105% | +$2.66M | 0.04% | 594 |
|
|
2018
Q3 | $3.58M | Buy |
41,500
+11,800
| +40% | +$841K | 0.03% | 771 |
|
|
2018
Q2 | $1.72M | Buy |
29,700
+7,200
| +32% | +$352K | 0.01% | 1256 |
|
|
2018
Q1 | $907K | Sell |
22,500
-16,400
| -42% | -$619K | 0.01% | 1603 |
|
|
2017
Q4 | $1.36M | Buy |
38,900
+26,100
| +204% | +$867K | 0.01% | 1461 |
|
|
2017
Q3 | $424K | Buy |
12,800
+300
| +2% | +$9.84K | ﹤0.01% | 2217 |
|
|
2017
Q2 | $434K | Sell |
12,500
-10,200
| -45% | -$297K | ﹤0.01% | 2072 |
|
|
2017
Q1 | $568K | Buy |
+22,700
| New | +$472K | 0.01% | 1769 |
|
|
2016
Q4 | – | Sell |
-1,900
| Closed | -$35K | – | 4840 |
|
|
2016
Q3 | $35K | Buy |
+1,900
| New | +$33.3K | ﹤0.01% | 3541 |
|
Other funds holding TDOC
VPM
VCM
VC
Group One Trading's TDOC Position: Q1 2026 in Review
Group One Trading increased its Teladoc Health (TDOC) stake by 40% in Q1 2026, buying an estimated $340K and bringing the position to 212,759 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #2574.
Group One Trading first reported a position in TDOC in Q3 2017 and has held it in 26 quarters since. The position peaked at $54M in Q1 2021. 322 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.
- Group One Trading held 212,759 shares of Teladoc Health worth $1.16M as of Q1 2026.
- Group One Trading bought 60,560 Teladoc Health shares in Q1 2026, an estimated $340K.
- Teladoc Health made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #2574 holding.
- Group One Trading first reported a position in Teladoc Health in Q3 2017 and has held it in 26 quarters since.
- Group One Trading's Teladoc Health position peaked at $54M in Q1 2021.
- 322 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.